Clifford Chance advised Keymed Biosciences on the deal. Keymed Biosciences (HKSe: 02162) signed a licensing agreement granting Platina the exclusive worldwide rights to develop, manufacture and...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Keymed Biosciences on the deal. Timberlyne Therapeutics, Inc. announced its US$180 million Series A financing to advance the development of CM313. Investors Abingworth,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Sanofi on the deal. Global healthcare company Sanofi announced the acquisition of exclusive rights to develop and commercialise aficamten in Greater China from...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Sanofi on the deal. Global healthcare company Sanofi announced the acquisition of exclusive rights to develop and commercialise aficamten in Greater China from...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Keymed Biosciences (Chengdu) Co., Ltd. on the deal. Keymed Biosciences (Chengdu) Co., Ltd. completed an out-licensing transaction with Belenos Biosciences, Inc.to exclusively...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Asian Development Bank (ADB) on the deal. The Asian Development Bank (ADB) and Greenway Grameen Infra Private Limited signed a $6.5 million senior...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Pegasus Digital Mobility Acquisition Corp. while Gleiss Lutz represented Gebr. Schmid GmbH. Gebr. Schmid GmbH (SCHMID Group) announced its planned listing on the New...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised BlackRock on the deal. BlackRock provided a US$150 million term loan facility for Puttshack, a tech-infused mini golf entertainment venue. The proceeds...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Informa PLC on the deal. Linklaters advised Montagu. Informa PLC sold Emerging Portfolio Funds Research (EPFR) to Montagu Private Equity LLP for US$193...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Root on the deal. Clifford Chance, working alongside Maples and Calder, advised BlackRock. Root, Inc., the parent company of Root Insurance Company,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Volvo Car AB and its main shareholder, Geely Sweden, on the deal. White & Case advised the underwriting syndicate. The proposed IPO is...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
You must be a Standard 1 Year member to access this content.
